Verde Science Inc VRCI
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Shares Outstanding
- 23.87M
- Market Cap
- $23.87
- Volume/Avg
- 250 / 35,157
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Verde Science Inc operates as a pharmaceutical research and development company, that engages in the development of pharmaceutical drugs utilizing cannabis resin. The company is focused on the discovery of drugs and treatment modalities, as well as diagnostic devices and pharmaceutical delivery systems for the treatment of diseases and medical issues. It is focused on developing medicinal formulations from cannabinoids and tetrahydrocannabinol (THC) compounds for the treatment of various issues, such as migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 2
- Website
- https://www.verdescienceinc.com
Valuation
|
Metric
|
VRCI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
VRCI
Financial Strength
|
Metric
|
VRCI
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.01 |
Interest Coverage | −2.42 |
Quick Ratio
No chart available
Profitability
|
Metric
|
VRCI
|
|---|---|
Return on Assets (Normalized) | −11,468.11% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|t?H%Sy | LOCK|Kg%lm | $133B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|^CV#$Mk | LOCK|$^K< | $83B | |||
| Moderna Inc
MRNA
| LOCK|@#?#g<f | LOCK|s# | $80B | |||
| argenx SE ADR
ARGX
| LOCK|#wtNT$ | LOCK|@!% | $55B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|d#@Kcg | LOCK|ry! | $45B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|$g?ZHNs | LOCK|#XM^j | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|#lHTh?@? | LOCK|W^#? | $28B | |||
| Incyte Corp
INCY
| LOCK|fL%#j> | LOCK|@< | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|<y@#qgy | LOCK|Q&$ | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|&n>L&JR | LOCK|wkC | $14B |
United States